2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of … F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ... European heart journal 41 (1), 111-188, 2020 | 8133 | 2020 |
Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials N Mansoor, KJ Vinknes, MB Veierød, K Retterstøl British Journal of Nutrition 115 (3), 466-479, 2016 | 504 | 2016 |
Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study MH Wennersberg, A Smedman, AM Turpeinen, K Retterstøl, S Tengblad, ... The American journal of clinical nutrition 90 (4), 960-968, 2009 | 196 | 2009 |
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several‐fold in patients with atorvastatin‐induced myopathy M Hermann, MP Bogsrud, E Molden, A Åsberg, BU Mohebi, L Ose, ... Clinical Pharmacology & Therapeutics 79 (6), 532-539, 2006 | 167 | 2006 |
ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue R Westerberg, JE Månsson, V Golozoubova, IG Shabalina, EC Backlund, ... Journal of Biological Chemistry 281 (8), 4958-4968, 2006 | 165 | 2006 |
Mortality among patients with familial hypercholesterolemia: A registry‐based study in Norway, 1992–2010 L Mundal, M Sarancic, L Ose, PO Iversen, JK Borgan, MB Veierød, ... Journal of the American heart Association 3 (6), e001236, 2014 | 149 | 2014 |
Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia ÅL Amundsen, J Khoury, PO Iversen, C Bergei, L Ose, S Tonstad, ... Atherosclerosis 189 (2), 451-457, 2006 | 133 | 2006 |
Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review I Narverud, K Retterstøl, PO Iversen, B Halvorsen, T Ueland, SM Ulven, ... Atherosclerosis 235 (2), 299-309, 2014 | 120 | 2014 |
Pregnancy outcomes in familial hypercholesterolemia: a registry-based study I Toleikyte, K Retterstøl, TP Leren, PO Iversen Circulation 124 (15), 1606-1614, 2011 | 106 | 2011 |
Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death HW Krogh, L Mundal, KB Holven, K Retterstøl European heart journal 37 (17), 1398-1405, 2016 | 104 | 2016 |
HypoCol (red yeast rice) lowers plasma cholesterol–a randomized placebo controlled study MP Bogsrud, L Ose, G Langslet, I Ottestad, EC Strøm, TA Hagve, ... Scandinavian Cardiovascular Journal 44 (4), 197-200, 2010 | 104 | 2010 |
Effect of low carbohydrate high fat diet on LDL cholesterol and gene expression in normal-weight, young adults: a randomized controlled study K Retterstøl, M Svendsen, I Narverud, KB Holven Atherosclerosis 279, 52-61, 2018 | 97 | 2018 |
Oxidised fish oil does not influence established markers of oxidative stress in healthy human subjects: a randomised controlled trial I Ottestad, G Vogt, K Retterstøl, MC Myhrstad, JE Haugen, A Nilsson, ... British Journal of Nutrition 108 (2), 315-326, 2012 | 91 | 2012 |
Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia A Græsdal, MP Bogsrud, KB Holven, MS Nenseter, I Narverud, G Langslet, ... Journal of clinical lipidology 6 (4), 331-339, 2012 | 85 | 2012 |
Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors MCW Myhrstad, K Retterstøl, VH Telle-Hansen, I Ottestad, B Halvorsen, ... Inflammation research 60, 309-319, 2011 | 83 | 2011 |
Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia LJ Mundal, J Igland, MB Veierød, KB Holven, L Ose, RM Selmer, T Wisloff, ... Heart 104 (19), 1600-1607, 2018 | 70 | 2018 |
Polyphenol-rich juices reduce blood pressure measures in a randomised controlled trial in high normal and hypertensive volunteers TE Tjelle, L Holtung, SK Bøhn, K Aaby, M Thoresen, SÅ Wiik, I Paur, ... British Journal of Nutrition 114 (7), 1054-1063, 2015 | 69 | 2015 |
Lipoprotein (a) levels in coronary heart disease-susceptible and-resistant patients with familial hypercholesterolemia MS Nenseter, HW Lindvig, T Ueland, G Langslet, L Ose, KB Holven, ... Atherosclerosis 216 (2), 426-432, 2011 | 69 | 2011 |
No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy MP Bogsrud, G Langslet, L Ose, KE Arnesen, MC Sm stuen, UF Malt, ... Scandinavian Cardiovascular Journal 47 (2), 80-87, 2013 | 60 | 2013 |
Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992–2013 L Mundal, J Igland, L Ose, KB Holven, MB Veierød, TP Leren, K Retterstøl European journal of preventive cardiology 24 (2), 137-144, 2017 | 59 | 2017 |